Home>Bulk Products>3-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole

About Us

Founded in 2014, BLD Pharmatech Ltd. is a leading supplier and manufacturer of research chemicals to pharmaceutical companies, universities, biotech companies,healthcare industries,contract research organizations etc.


With its own R&D center in Shanghai, BLD Pharmatech Ltd. main field of expertise covers the development and production of heterocycles,boronic acids, amino acids, metal catalysts and chiral compounds.

Qualifications

DUNS: 560440352

BD300269[1227911-51-4]3-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole*

Specific Information

Purity : 98+% Specific Rotation :
NMR(H/C/F/S/P) : E.E. :
HPLC : Water Content :
Polymerization Inhibitor : Single Impurity :
Melting Point : Density :
Packaging : Solubility :
Name Note : Acetic Acid :
Beilstein : Grade :
Specific Gravity : Viscosity :
Others :

Product Details

Cat No. : BD300269 Synonyms : 3-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole
CAS No. : 1227911-51-4 MDL NO : MFCD15071447
Formule : C14H19BN2O2 InChI Key :
M.W : 258.12 Pubchem ID : 58504489
Boiling Point : No data available

Safety

Signal Word : Warning Class :
Precautionary Statements : P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P362-P403+P233-P405-P501 UN# :
Hazard Statements : H315-H319-H335 Packing Group :
GHS Pictogram:

R&D Center